{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:07:42Z","timestamp":1789718862352,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T00:00:00Z","timestamp":1728864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004756","name":"Emil Aaltonen Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["311939"],"award-info":[{"award-number":["311939"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Research Council of Finland","doi-asserted-by":"publisher","award":["307057"],"award-info":[{"award-number":["307057"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004155","name":"Magnus Ehrnrooth Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004212","name":"Paivikki and Sakari Sohlberg Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030846","name":"Biokeskus Kuopio, It\u00e4-Suomen yliopisto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013840","name":"Biocenter Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013840","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007753","name":"University of Eastern Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007753","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejps.2024.106937","type":"journal-article","created":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T14:09:33Z","timestamp":1729001373000},"page":"106937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The L-type amino acid transporter 1 enhances drug delivery to the mouse pancreatic beta cell line (MIN6)"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7526-0419","authenticated-orcid":false,"given":"Janne","family":"Tampio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed B.","family":"Montaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juulia","family":"J\u00e4rvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Lehtonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaro J.","family":"Jalkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Reinisalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarja","family":"Kokkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Laakso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Rys\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Kauppinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina M.","family":"Huttunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2024.106937_bib0001","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-020-05203-7","article-title":"Organisation of the human pancreas in health and in diabetes","author":"Atkinson","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejps.2024.106937_bib0002","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1021\/acs.molpharmaceut.2c00594","article-title":"Structural Features Affecting the Interactions and Transportability of LAT1-Targeted Phenylalanine Drug Conjugates","volume":"20","author":"Bahrami","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2024.106937_bib0003","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00424-020-02383-4","article-title":"Glucose transporters in pancreatic islets","volume":"472","author":"Berger","year":"2020","journal-title":"Pflugers. Arch."},{"key":"10.1016\/j.ejps.2024.106937_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108233","article-title":"Review of methods for detecting glycemic disorders","author":"Bergman","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.ejps.2024.106937_bib0005","doi-asserted-by":"crossref","first-page":"12079","DOI":"10.1073\/pnas.96.21.12079","article-title":"Selective expression of the large neutral amino acid transporter at the blood\u2013brain barrier","volume":"96","author":"Boado","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2024.106937_bib0006","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1074\/jbc.RA118.006378","article-title":"Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells","volume":"294","author":"Br\u00f6er","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2024.106937_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41580-020-00317-7","article-title":"Mechanisms controlling pancreatic islet cell function in insulin secretion","author":"Campbell","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejps.2024.106937_bib0008","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1074\/jbc.RA117.001342","article-title":"The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)","volume":"293","author":"Cormerais","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2024.106937_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/cells11152330","article-title":"Pseudoislet aggregation of pancreatic \u03b2-Cells improves glucose stimulated insulin secretion by altering glucose metabolism and increasing ATP production","volume":"11","author":"Cornell","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2024.106937_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.phyplu.2021.100072","article-title":"Beta cell protective effect of Curcuma longa and Piper nigrum in cytokine cocktail induced apoptosis in Min6 pancreatic beta cells","volume":"1","author":"Damame","year":"2021","journal-title":"Phytomedicine Plus"},{"key":"10.1016\/j.ejps.2024.106937_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2020.106914","article-title":"In vitro model using cytokine cocktail to evaluate apoptosis in Min6 pancreatic beta cells","volume":"106","author":"Damame","year":"2020","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejps.2024.106937_bib0012","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-19600-x","article-title":"Cytokine-mediated changes in K+ channel activity promotes an adaptive Ca2+ response that sustains \u03b2-cell insulin secretion during inflammation","volume":"8","author":"Dickerson","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2024.106937_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23116144","article-title":"Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline","author":"Ehtewish","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2024.106937_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118714","article-title":"L-Type amino acid transporter 1 (LAT1)-utilizing prodrugs are carrier-selective despite having low affinity for organic anion transporting polypeptides (OATPs)","volume":"571","author":"Huttunen","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106937_bib0015","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/acs.molpharmaceut.2c00948","article-title":"Sodium-Dependent Neutral Amino Acid Transporter 2 Can Serve as a Tertiary Carrier for L-Type Amino Acid Transporter 1-Utilizing Prodrugs","volume":"20","author":"Huttunen","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2024.106937_bib0016","article-title":"l-Type Amino Acid Transporter 1 (LAT1\/Lat1)-Utilizing Prodrugs Can Improve the Delivery of Drugs into Neurons","volume":"9","author":"Huttunen","year":"2019","journal-title":"Astrocytes and Microglia. Sci Rep"},{"key":"10.1016\/j.ejps.2024.106937_bib0017","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bioorg.2018.09.018","article-title":"Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of ketoprofen","volume":"81","author":"Huttunen","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2024.106937_bib0018","doi-asserted-by":"crossref","first-page":"5740","DOI":"10.1021\/acs.jmedchem.6b00190","article-title":"A selective and slowly reversible inhibitor of l -type amino acid transporter 1 (LAT1) potentiates antiproliferative drug efficacy in cancer cells","volume":"59","author":"Huttunen","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2024.106937_bib0019","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-008-9532-4","article-title":"Quantitative Atlas of Membrane Transporter Proteins: development and Application of a Highly Sensitive Simultaneous LC\/MS\/MS Method Combined with Novel In-silico Peptide Selection Criteria","volume":"25","author":"Kamiie","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2024.106937_bib0020","doi-asserted-by":"crossref","unstructured":"Kanai, Y., Segawa, H., Miyamoto, K.-I., Uchino, H., Takeda, E., Endou, H., 1998. Expression Cloning and Characterization of a Transporter for Large Neutral Amino Acids Activated by the Heavy Chain of 4F2 Antigen (CD98)*.","DOI":"10.1074\/jbc.273.37.23629"},{"key":"10.1016\/j.ejps.2024.106937_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21207573","article-title":"The heavy chain 4F2hc modulates the substrate affinity and specificity of the light chains LAT1 and LAT2","volume":"21","author":"Kantipudi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2024.106937_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104921","article-title":"Molecular characteristics supporting L-Type amino acid transporter 1 (LAT1)-mediated translocation","volume":"112","author":"K\u00e4rkk\u00e4inen","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejps.2024.106937_bib0023","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2008.09.021","article-title":"Differential metabolic effects of pravastatin and simvastatin in hypercholesterolemic patients","volume":"204","author":"Koh","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejps.2024.106937_bib0024","doi-asserted-by":"crossref","DOI":"10.1042\/AN20120007","article-title":"Aspects of astrocyte energy metabolism, amino acid neurotransmitter homoeostasis and metabolic compartmentation","author":"Kreft","year":"2012","journal-title":"ASN. Neuro"},{"key":"10.1016\/j.ejps.2024.106937_bib0025","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.bjp.0707259","article-title":"Non-steroidal anti-inflammatory drugs increase insulin release from beta cells by inhibiting ATP-sensitive potassium channels","volume":"151","author":"Li","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2024.106937_bib0026","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbrc.2006.02.003","article-title":"MIN6 beta-cell-beta-cell interactions influence insulin secretory responses to nutrients and non-nutrients","volume":"343","author":"Luther","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejps.2024.106937_bib0027","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/endo-127-1-126","article-title":"Establishment of a pancreatic beta cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms","volume":"127","author":"Miyazaki","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejps.2024.106937_bib0028","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1021\/acschemneuro.0c00564","article-title":"L-Type Amino Acid Transporter 1 Enables the Efficient Brain Delivery of Small-Sized Prodrug across the Blood-Brain Barrier and into Human and Mouse Brain Parenchymal Cells","volume":"11","author":"Montaser","year":"2020","journal-title":"ACS. Chem. Neurosci."},{"key":"10.1016\/j.ejps.2024.106937_bib0029","first-page":"217","article-title":"Unique and selective expression of l-amino acid transporter 1 in human tissue as well as being an aspect of oncofetal protein","volume":"29","author":"Nakada","year":"2014","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.ejps.2024.106937_bib0030","first-page":"43","article-title":"Branched Chain Amino Acids","volume":"26","author":"Neinast","year":"2018","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.ejps.2024.106937_bib0031","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/mas.21540","article-title":"The Skyline ecosystem: informatics for quantitative mass spectrometry proteomics","volume":"39","author":"Pino","year":"2020","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.ejps.2024.106937_bib0032","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jconrel.2017.06.023","article-title":"L-type amino acid transporter 1 utilizing prodrugs: how to achieve effective brain delivery and low systemic exposure of drugs","volume":"261","author":"Puris","year":"2017","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.ejps.2024.106937_bib0033","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-018-2532-0","article-title":"Transport of Pregabalin Via L--Type Amino Acid Transporter 1 (SLC7A5) in human brain capillary endothelial cell line","volume":"35","author":"Takahashi","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2024.106937_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120565","article-title":"Improved l-Type amino acid transporter 1 (LAT1)-mediated delivery of anti-inflammatory drugs into astrocytes and microglia with reduced prostaglandin production","volume":"601","author":"Tampio","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2024.106937_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109560","article-title":"Hemocompatible L-Type amino acid transporter 1 (LAT1)-Utilizing prodrugs of perforin inhibitors can accumulate into the pancreas and alleviate inflammation-induced apoptosis","volume":"345","author":"Tampio","year":"2021","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejps.2024.106937_bib0036","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.1021\/acs.molpharmaceut.2c00328","article-title":"L-type Amino Acid Transporter 1 Utilizing Ferulic Acid Derivatives Show Increased Drug Delivery in the Mouse Pancreas Along with Decreased Lipid Peroxidation and Prostaglandin Production","volume":"19","author":"Tampio","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejps.2024.106937_bib0037","doi-asserted-by":"crossref","DOI":"10.1186\/2045-8118-10-21","volume":"10","author":"Uchida","year":"2013","journal-title":"Fluids. Barriers. CNS."},{"key":"10.1016\/j.ejps.2024.106937_bib0038","doi-asserted-by":"crossref","first-page":"811","DOI":"10.33549\/physiolres.933469","article-title":"The effect of very-low-calorie diet on mitochondrial dysfunction in subcutaneous adipose tissue and peripheral monocytes of obese subjects with type 2 diabetes mellitus","volume":"66","author":"Urbanov\u00e1","year":"2017","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ejps.2024.106937_bib0039","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0305-9","article-title":"Glucose transporter 1 critically controls microglial activation through facilitating glycolysis","volume":"14","author":"Wang","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejps.2024.106937_bib0040","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/dc17-1642","article-title":"Genetic support for a causal role of insulin resistance on circulating branched-chain amino acids and inflammation","volume":"40","author":"Wang","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejps.2024.106937_bib0041","article-title":"The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation","volume":"15","author":"Wu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2024.106937_bib0042","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/jsre.2001.6285","article-title":"Cytokine-induced metabolic dysfunction of MIN6 \u03b2 cells is nitric oxide independent","volume":"101","author":"Wu","year":"2001","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.ejps.2024.106937_bib0043","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41586-019-1011-z","article-title":"Structure of the human LAT1\u20134F2hc heteromeric amino acid transporter complex","volume":"568","author":"Yan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2024.106937_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101489","article-title":"Mitochondrial complex I subunit deficiency promotes pancreatic \u03b1-cell proliferation","volume":"60","author":"Yu","year":"2022","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ejps.2024.106937_bib0045","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/labinvest.2015.112","article-title":"MiR-101a and miR-30b contribute to inflammatory cytokine-mediated \u03b2-cell dysfunction","volume":"95","author":"Zheng","year":"2015","journal-title":"Laboratory Investig."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724002501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098724002501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:29:38Z","timestamp":1777591778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098724002501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"alternative-id":["S0928098724002501"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106937","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The L-type amino acid transporter 1 enhances drug delivery to the mouse pancreatic beta cell line (MIN6)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2024.106937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106937"}}